Novartis sales calls up, down overall

Share this article:
Novartis is bucking the trend toward fewer sales calls to healthcare professionals.

Visits by the Swiss giant's sales force increased 7% in the first half of 2010, compared to the second half of 2009, according to SDI. Reps detailed Novartis' newly launched hypertension drug Valturna in around a fifth of those calls (19%). In addition, Reclast details were up 2.6% and Enablex details rose 14% for the six-month period.

Overall, industry sales calls dipped 1% in the first half. Calls by sales leader Pfizer decreased 2%, while runner-up Merck saw sales calls slide 16%, with 38% fewer details for Vytorin and 29% fewer for Zetia. Caller No. 3 GSK made 7% fewer calls to physicians, NPs and PAs.

“With the number of pharmaceutical sales reps being scaled back dramatically over the last few years, it's no surprise that sales calls across the industry are also declining,” said Jason Fox, associate director of syndicated analytics at SDI. “However, companies with new drugs or newly approved indications for existing drugs need to get the information into the hands of physicians and other practitioners, and in-person calls are still the most popular type of promotion, outside of product sampling.”

SDI calculates that sales rep calls and details accounted for 36% of the $11 billion pharma promotional spend in the first four months of 2010.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.